|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Inactivation of the Wipl phosphatase inhibits mammary tumorigenesis through p38 MARK- mediated activation of the p16 (Ink4a) -p19 (Aft) pathway 显示文摘 | Bulavin DV Phillips C Nannenga B | 2004 | Nat Genet2004，36，4： | 1 |
| 2 | PPM1D dephosphorylates Chkl and p53 and abrogates cell cycle checkpoints显示文摘 | Lu X Nannenga B Donehower LA | 2005 | Genes Dev2005，19，10： | 1 |
| 3 | Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice 显示文摘 | NANNENGA B LU X DUMBLE M | 2006 | Mol Carcinog2006，45，8： | 1 |
| 4 | Mice deficient for the wild-type p53-induced phosphatase gene (Wipl) exhibit defects in rep roductiveor-gans, immune function, and cell cycle control 显示文摘 | Choi J Nannenga B Demidov ON | 2002 | Mol Cell Biol2002，22，4： | 1 |
| 5 | Inactivation of the Wipl phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16 (Ink4a)-pl9 (Aft) pathway 显示文摘 | Bulavin DV Phillips C Nannenga B | 2004 | Nat Genet2004，36，4： | 1 |
| 6 | Inactivation of the Wipl phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16 (Ink4a)-p19 (Aft) pathway显示文摘 | Bulavin DV Phillips C Nannenga B | 2004 | Nat Genet2004，36，4： | 1 |
| 7 | Mice deficient for the wild-type p53-induced phosphatase gene (Wipl) exhibit defects in reproductive organs, immune function, and cell cycle control 显示文摘 | Choi J Nannenga B Demidov ON | 2002 | Mol CellBiol2002，22，4： | 1 |
| 8 | Inactivation of the Wipl phosphatase inhibits mammary tumorigenesis through p38 MAPK -mediated activation of the p16 (Ink4a)-p19 (Aft) pathway 显示文摘 | Bulavin DV Phillips C Nannenga B | 2004 | Nat Genet2004，36，4： | 1 |
| 9 | The p53 - induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair 显示文摘 | Lu X Bocangel D Nannenga B | 2004 | Mol Cell2004，15，4： | 1 |
| 10 | Inactivation of the Wipl phosphatase inhibits mammary tumorigenesis through p38 MAPK - mediated activation of the p16 (Ink4a) - pl9(Arf) pathway显示文摘 | Bulavin DV Phillips C Nannenga B | 2004 | Nat Genet2004，36，4： | 1 |
| 11 | Inactivation of the Wipl phosphatase inhibits mammary tumorigenesis through p38 MAPK - mediated activation of the p16^Ink4a - p19^Arf pathway显示文摘 | Bulavin DV Phillips C Nannenga B | 2004 | Nat Genet2004，36，4： | 1 |
| 12 | Mice deficient for the wild - type p53 - induced phosphatase gene ( Wipl ) exhibit defects in reproductiveor - gans,immune function, and cell cycle control 显示文摘 | Choi J Nannenga B Demidov ON | 2002 | Mol Cell Bid2002，22，4： | 1 |
| 13 | Mice deficient for the wild-type p53-induced phosphatase gene (Wipl) exhibit defects in reproductive organs, immune function, and cell cycle control 显示文摘 | Choi J Nannenga B Demidov ON | 2002 | Mol Cell Biol2002，22，4： | 1 |
| 14 | Inactivation of the Wipl phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway显示文摘 | Bulavin Dr Phillips C Nannenga B | 2004 | Nat Genet2004，36，4： | 1 |
| 15 | PPM1D dephos- phorylates Chkl and p53 and abrogates cell cycle check- points显示文摘 | Lu X Nannenga B Donehower LA | 2005 | Genes Dev2005，19，10： | 1 |
| 16 | Inactivation of the Wiplphosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf)pathway显示文摘 | Bulavin DV Phillips C Nannenga B | 2004 | NatGenet2004，36，4： | 1 |
| 17 | PPM1D dephosphorylates Chk1and p53 and abrogates cell cycle check-points显示文摘 | Lu X Nannenga B Donehower LA | 2005 | Genes Dev2005，19，10： | 1 |
| 18 | PPM1D dephosphorylates Chkl and p53 and abrogates cell cycle checkpoints 显示文摘 | Lu X Nannenga B Donehower L A | 2005 | Genes Dev2005，19，10： | 1 |
| 19 | Mice deficient for the Wild-type p53-induced phosphatase gene ( Wipl ) exhibit defects in reproductive organs, immune function, and cell cycle control显示文摘 | Choi J Nannenga B Demidov O D N | 2002 | Mol Cell Biol2002，22，4： | 1 |
| 20 | PPM 1 D dephosphorylates Chk 1 and p53 and abrogates cell cycle checkpoints 显示文摘 | Lu X Nannenga B Donehower LA | 2005 | Genes Development2005，19，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员